S&P 500 7,580.07 −1.82%
Nasdaq 25,437.00 −2.86%
S&P/TSX 35,620.03 −1.74%
Apple 344.63 −1.23%
Nvidia 204.64 −4.22%
Microsoft 521.91 −1.55%
Shopify 220.37 −5.70%
Royal Bank 283.93 −1.49%
CAD/USD 0.7154 +0.06%
CLOSED · 01:55 ET
Market ClerkRecap
Mon Nov 2 · markets closed1 signal on Oct 31129 insider buys this week · $10BCIRO short report next: Nov 14The week ahead
CS
INSIDER · TVTX · Travere Therapeutics, Inc. · SVP, CHIEF ACCOUNTING OFFICER

Calvin Sandra

Every open-market transaction filed under this name, Sep 15 to Sep 15.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$335K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 15TVTXTravere Therapeutics, Inc.SVP, CHIEF ACCOUNTING OFFICERSell300$63.66$19K−17.6%
Sep 15TVTXTravere Therapeutics, Inc.SVP, CHIEF ACCOUNTING OFFICERSell800$62.85$50K−16.6%
Sep 15TVTXTravere Therapeutics, Inc.SVP, CHIEF ACCOUNTING OFFICERSell4,275$62.13$266K−15.6%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.